First Page | Document Content | |
---|---|---|
Date: 2014-01-13 17:41:22Health Food and Drug Administration Pharmaceuticals policy Medicine Food law Dietary supplements United States Public Health Service Paul Offit Good manufacturing practice Federal Food Drug and Cosmetic Act Adverse effect Form FDA 483 | Microsoft Word - MRI_Rebuttal_NYTimes_Article_1-7-14_Final.docxAdd to Reading ListSource URL: www.mineralresourcesint.comDownload Document from Source WebsiteFile Size: 85,25 KBShare Document on Facebook |